CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04690088
NCT04690088N/ACompleted
CompareCT.gov

Remifentanilio Titravimo būdų Palyginimas, Remiantis pacientų Budimo Kokybe Ligotai Nutukusiems Pacientams po laparoskopinių skrandžio tūrio mažinimo operacijų

Lithuanian University of Health Sciences·observational·Posted Dec 30, 2020·Updated Dec 30, 2020

In Brief

An observational study for Morbid Obesity. Completed, enrolled 31 participants across 1 site.

Detailed Summary

Early recovery characteristics are important for patients' safety and operating room turnover. Our aim was to compare fundamental methods for dosing remifentanil during morbid obesity surgeries: a manual infusion and a target-controlled infusion (TCI). Throughout study, patient's recovery time was tracked and compared between the groups.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMorbid Obesity
CountriesLithuania
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 30, 2020
Enrollment StartOct 10, 2019
Primary CompletionDec 1, 2019
Study CompletionFeb 10, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.5 years ago